FTDI
ROIV icon

First Trust Direct Indexing’s Roivant Sciences ROIV Stock Holding History

First Trust Direct Indexing’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,285
Closed -$119K – 720
2024
Q3 		$119K Buy
+10,285
New +$117K 0.01% 952

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

First Trust Direct Indexing's ROIV Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Roivant Sciences (ROIV) in Q4 2024, closing a stake of 10,285 shares — an estimated $119K sold.

First Trust Direct Indexing first reported a position in ROIV in Q3 2024 and held it in 1 quarter. The position peaked at $119K in Q3 2024. 318 funds tracked by Wall St. Rank hold ROIV as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Roivant Sciences position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 10,285 Roivant Sciences shares in Q4 2024, an estimated $119K.
  • First Trust Direct Indexing first reported a position in Roivant Sciences in Q3 2024 and held it in 1 quarter.
  • First Trust Direct Indexing's Roivant Sciences position peaked at $119K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.